This population-based, case-control, family aggregation study examines the frequency and range of neuropsychiatric conditions that occur within individual first-degree and second-degree relatives of patients with amyotrophic lateral sclerosis.
This cohort modelling study constructs biomarker-based prognostic models that enable determination of future Alzheimer disease dementia in patients with mild cognitive impairment.
This study evaluates the relationship between bone mineral density and intracranial aneurysm.
This study presents a genetic locus for intracranial arachnoid cysts.
This study use seizure risk factors from electroencephalography and clinical history to create a simple scoring system for predicting the probability of seizures in patients with acute illness.
This cohort study identifies prognostic factors for immunosuppressive treatment in patients with neurosarcoidosis and assesses the association of such treatment with relapse of the disease.
This study compares the prevalence of tinnitus among patients who underwent medial temporal lobe resection, matched controls, and individuals with self-reported epilepsy to determine whether medial temporal lobe removal is associated with tinnitus.
A 30-year-old woman with a remote history of Hemophilus influenzae type b meningitis causing quadraparesis was admitted to the hospital with Candida fungemia.
This Viewpoint discusses the importance of the art of the clinical examination.
This imaging substudy of the Harvard Aging Brain Study examined associations between subjective cognitive decline and global β-amyloid and tau burdens in regions of interest in clinically healthy older adults.
This secondary analysis reports on the association of low-dose and standard-dose intravenous alteplase treatment with age, ethnicity (Asian vs non-Asian), and severity of acute ischemic stroke among patients in the ENCHANTED randomized clinical trial.
This case series describes the clinical presentation of optic nerve infiltration, its imaging characteristics, and outcomes in patients with primary central nervous system lymphomas.